Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

137.71 -4.57 (-3.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,977,768
Open 138.41
Bid (Size) 136.00 (5)
Ask (Size) 137.29 (1)
Prev. Close 142.28
Today's Range 136.29 - 144.13
52wk Range 119.01 - 497.49
Shares Outstanding 400,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Blue-Chip Tech Stocks to Buy Now
Off and on the price chart, these three blue-chip tech stocks look great to buy following earnings beats and attractive price charts. 
Via InvestorPlace
Moderna to Present at the UBS 2022 Global Healthcare Conference
CAMBRIDGE, MA / ACCESSWIRE / May 18, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in a... 
From Moderna, Inc.
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property

Performance

YTD
-41.41%
-41.41%
1 Month
-11.01%
-11.01%
3 Month
-9.29%
-9.29%
6 Month
-43.15%
-43.15%
1 Year
-13.68%
-13.68%

More News

Read More
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, May 18
Via Benzinga
Moderna's Chairman Defends Executive Hiring Process After Firing New CFO In Just One Day
Via Benzinga
IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program
From Moderna, Inc.
Via AccessWire
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
Via Benzinga
Pfizer Retakes A Key Line — And Drags BioNTech, Moderna With It
Via Investor's Business Daily
Looking At Moderna's Recent Whale Trades
Via Benzinga
Moderna Announces Advancements in mRNA Platform Science for Application Across Multiple Diseases at Science and Technology Day
From Moderna, Inc.
Via AccessWire
Moderna And 3 Other Stocks Insiders Are Selling
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, May 16
Via Benzinga
Moderna Justifies It Did Not Know About Investigation On Its New CFO: WSJ
Via Benzinga
7 Undervalued Blue-Chip Stocks to Buy Now
Via InvestorPlace
Johnson & Johnson Stock: A Rare Bright Spot in the Market
Via InvestorPlace
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
Via Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
Via Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Via Benzinga
Moderna Stock Will Come Back Stronger After CFO Exit
Via InvestorPlace
Moderna Concludes FDA Submission For Its COVID-19 Shot In Adolescents, Kids
Via Benzinga
Why Did Moderna CFO Exit Just A Day After Taking Charge
Via Benzinga
INO Stock Plunges 25% as Inovio Pharmaceuticals Swaps Vaccine Focus
Via InvestorPlace
Departure of Jorge Gomez and Continuation of David Meline as Chief Financial Officer
From ModernaTX, Inc
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
7 Biotech Stocks With Key Catalysts for May
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.